Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 8Brain Neoplasms 5Neoplasms 4Glioma 3Medulloblastoma 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Ketosis 1Insulin Resistance 1Gliosarcoma 1Diabetes Mellitus 1Colonic Neoplasms 1Cognitive Dysfunction 1Chondrosarcoma 1Cholangiocarcinoma 1Astrocytoma 1

Interventions

Cyclophosphamide 35Temozolomide 33Filgrastim 26Etoposide 26Carboplatin 25Vincristine 22Cisplatin 22Radiotherapy 20Magnetic Resonance Spectroscopy 18Thiotepa 14Irinotecan 13Granulocyte Colony-Stimulating Factor 12Peripheral Blood Stem Cell Transplantation 11Lomustine 11Specimen Handling 9Radiation 9Melphalan 9etoposide phosphate 8Topotecan 8Methotrexate 8X-Rays 7Platinum 7Phantoms, Imaging 7sonidegib 6Biopsy 61,2-diaminocyclohexaneplatinum II citrate 6sargramostim 5palbociclib 5Nuclear Medicine Department, Hospital 5HhAntag691 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Medulloblastoma × Metformin × CNS × Clear all
NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting
140 enrolled
CNS

Medulloblastoma, Cognitive Dysfunction

NCT02040376 2025-07-16

Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma

The Hospital for Sick Children

Phase 3 Completed
24 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡